Allegro Ophthalmics Announces Positive Topline Results from DEL MAR Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema
SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Allegro Ophthalmics announced that the DEL MAR Phase 2b clinical trial evaluating Luminate (ALG-1001) in 136 patients with diabetic macular edema met its primary and secondary endpoints.
